Posterior Uveitis: Clinical Trials

3 trials for Posterior Uveitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 21Completed 1

Follow Posterior Uveitis: new trials by email Literature Review of Posterior Uveitis trials Research Report on Posterior Uveitis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis
Sham Injection, FAI Insert - Posterior Uveitis, Intermediate Uveitis
Phase 3CompletedEyePoint Pharmaceuticals, Inc.1532015-06-022020-07-21
A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis
Dexamethasone, dexamethasone, Sham injection - Intermediate Uveitis, Posterior Uveitis
Phase 2 / Phase 3CompletedAllergan2292006-05-012011-04-14
Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB)
Cyclosporin A, Interferon-alpha2a - Behcet's Disease, Panuveitis
Phase 3CompletedUniversity Hospital Tuebingen372004-11-012018-05-17

Narrower conditions

Uveitis, Posterior (3)  ·  Panuveitis (2)  ·  Uveitis, Intermediate (2)  ·  Behcet Syndrome (1)  ·  Retinal Vasculitis (1)

Broader conditions

Eye Diseases (3)  ·  Uveal Diseases (3)  ·  Uveitis (3)  ·  Cardiovascular Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Hereditary Autoinflammatory Diseases (1)  ·  Mouth Diseases (1)  ·  Panuveitis (1)  ·  Retinal Diseases (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Genetic (1)  ·  Skin Diseases, Vascular (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Stomatognathic Diseases (1)

Interventions

salicylhydroxamic acid (2)  ·  Cyclosporine (1)  ·  Dexamethasone (1)  ·  Fluocinolone Acetonide (1)  ·  Interferon alpha-2 (1)

Sponsors

Allergan (1)  ·  EyePoint Pharmaceuticals, Inc. (1)  ·  University Hospital Tuebingen (1)

Countries

Germany (2)  ·  India (2)  ·  Australia (1)  ·  Austria (1)  ·  Brazil (1)  ·  Canada (1)  ·  Czechia (1)  ·  France (1)  ·  Greece (1)  ·  Israel (1)  ·  Poland (1)  ·  Portugal (1)  ·  South Africa (1)  ·  South Korea (1)  ·  Spain (1)

Top investigators

Flavio Leonin Jr., MD (1)  ·  Ina Koetter, MD (1)

Results publications

PMID 21220619, PMID 23411886, PMID 23761087, PMID 38027419